Picton Mahoney Asset Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20K Hold
125,000
﹤0.01% 989
2025
Q4
$36.9K Hold
125,000
﹤0.01% 908
2025
Q3
$36K Hold
125,000
﹤0.01% 749
2025
Q2
$36K Buy
+125,000
New +$25.8K ﹤0.01% 658

Other funds holding TDACW

Picton Mahoney Asset Management's TDACW Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 125,000 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Picton Mahoney Asset Management first reported a position in TDACW in Q2 2025 and has held it in 4 quarters since. The position peaked at $36.9K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Picton Mahoney Asset Management held 125,000 shares of Translational Development Acquisition Corp Warrants worth $20K as of Q1 2026.
  • Picton Mahoney Asset Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #989 holding.
  • Picton Mahoney Asset Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 4 quarters since.
  • Picton Mahoney Asset Management's Translational Development Acquisition Corp Warrants position peaked at $36.9K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.